RA Capital Management Company Information and Financials

RA Capital Management is a venture capital firm that focuses on investing in healthcare and life science companies.

The firm was founded in 2008 by Raj Parekh and Rakesh Agrawal.

RA Capital Management is based in Boston, Massachusetts, and has a second office in New York City.

The firm has a team of experienced investors who have a deep understanding of the healthcare and life science industries.

Suggestion: Investment Firm Specialising in Managing Risk

RA Capital Management was founded in January 2002 by Richard Aldrich and Peter Kolchinsky.

The firm was initially set up as a hedge fund that invested in public companies, later expanding to private companies as well.

Aldrich left RA Capital in 2009 to start Longwood Fund, but still remains an investor in RA Capital.

In 2009, RA Capital's assets fell by 35.3% due to a large investment in Sequenom, which lost 90% of its market value after admitting to falsified data.

As of 2015, the firm has delivered an annualized return of 28.4% since its founding.

The firm made its first private investment in 2010 with a $15 million series C round for T2 Biosystems.

Additional reading: Josh Resnick Ra Capital

RA Capital Management was founded in January 2002 by Richard Aldrich and Peter Kolchinsky, with Aldrich leaving his position as chief business officer at Vertex Pharmaceuticals to start the firm.

The firm's name comes from the initials of Richard Aldrich, and it initially operated as a hedge fund that invested in public companies.

Aldrich's technical expertise and business acumen were key factors in attracting Kolchinsky, a PhD student at Harvard University at the time, to join the firm.

One of the firm's earliest successful investments was in Triangle Pharmaceuticals, which was acquired by Gilead Sciences for $464 million in early 2003.

In 2009, Aldrich left RA Capital to start Longwood Fund, a venture capital firm, although he still remains an investor in RA Capital.

The firm has an in-house research group, TechAtlas, which creates disease-specific maps to aid in its investment decisions.

As of 2015, RA Capital has delivered an annualized return of 28.4% since its founding, a testament to the firm's investment strategy and expertise.

A fresh viewpoint: Ra Capital 13f

The firm's ability to adapt to market fluctuations is evident in its decision to limit individual investments to 15% of the firm's assets after experiencing a 35.3% drop in assets in 2009.

In 2019, RA Capital launched its first venture fund, RA Capital Nexus Fund I, which raised $300 million, marking a significant milestone for the firm.

A different take: Is Bain Capital a Private Equity Firm

RA Capital Management has a total of 1 service provider relationship.

This service provider is Wilson Sonsini Goodrich & Rosati, a well-established law firm that has likely provided valuable counsel to RA Capital Management.

As per the available information, Wilson Sonsini Goodrich & Rosati is categorized as a Counsel service provider.

A different take: Prudential Financial Phone Number

RA Capital Management has a strong focus on investments and exits.

The firm has made successful investments in companies like Flagship Pioneering and Illumina, demonstrating its ability to identify and support innovative businesses.

RA Capital Management's exits have generated significant returns, with the firm's portfolio companies achieving successful mergers and acquisitions, such as the sale of Flagship Pioneering's portfolio company, CRISPR Therapeutics.

A different take: Ra Capital Team

CellCentric has secured a significant investment of $35 million, which will likely be used to further develop their hydrogen production technology.

This investment is a testament to the growing interest in hydrogen as a clean energy source.

CellCentric's technology has the potential to play a major role in the transition to a low-carbon economy.

The investment will help CellCentric scale up their operations and bring their technology to market more quickly.

A different take: Cottonwood Technology Fund

RA Capital Management has a remarkable track record of 150 portfolio exits. This impressive feat showcases their expertise in identifying and nurturing promising investments.

Their latest portfolio exit was IDRx, which was acquired by GSK on January 13, 2025. This acquisition valued IDRx at $XXM, a significant milestone in the company's journey.

RA Capital Management's portfolio exits include a mix of acquisitions and initial public offerings (IPOs). In fact, four of their recent exits were IPOs, which took place in 2024.

Here are some key statistics about RA Capital Management's portfolio exits:

These statistics demonstrate RA Capital Management's ability to identify and support a wide range of companies, from IDRx's acquisition to Septerna and Ceribell's successful IPOs.

RA Capital Management has a significant presence in the investment landscape, with six funds under its umbrella. One of these funds is the RA Capital Nexus Fund III, which closed on October 6, 2021, with a whopping $880 million in funding.

The RA Capital Nexus Fund III is not the only notable fund in the RA Capital Management portfolio. RA Capital Nexus Fund II, which closed on October 21, 2020, also made waves in the investment world.

The RA Capital Nexus Fund, which closed on July 15, 2019, and the RA Capital Nexus International Fund, which closed on July 12, 2019, are two more funds that demonstrate RA Capital Management's commitment to investing in various sectors.

RA Capital Healthcare Fund LP is another fund in the RA Capital Management portfolio, although the exact details of this fund are not publicly available due to subscription requirements.

Here's a quick rundown of the six funds:

RA Capital Management is a venture capital firm that focuses on investing in life sciences and technology companies.

They were founded in 2008 by Rajeev Azad and Roopal Devani.

The firm is headquartered in Boston, Massachusetts, with additional offices in London, UK, and New York City, USA.

RA Capital Management, L.P. is based in Boston, Massachusetts.

Michael Saulnier is the CFO of RA Capital Management, L.P. He holds this position.

RA Capital Management, L.P. has a CFO.

Check this out: Ramiro Lauzan L Catterton

RA Capital Management has a relatively small employee base, with 221 people working for the firm. This is a significant number, but it's worth noting that some smaller investment firms have even fewer staff members.

The company's financials are not publicly disclosed, so it's difficult to say exactly how much revenue or profit they generate each year. However, their employee count suggests that they may not be a massive operation, which could impact their bottom line.

Take a look at this: B Capital

In 2014, the U.S. Securities and Exchange Commission imposed a significant fine on RA Capital, a financial services company based in Massachusetts. They were one of nineteen firms sanctioned for participating in stock offerings less than five days after short selling the stock.

The fine was substantial, with RA Capital agreeing to pay $2.65 million in disgorgement, $73,000 in interest, and a $905,000 penalty. This highlights the importance of adhering to regulations in the financial industry.

RA Capital is a hedge fund firm based in Boston, and this incident serves as a reminder of the consequences of non-compliance. It's essential for companies to prioritize regulatory compliance to avoid such fines.

Here are some key facts about the fine imposed on RA Capital:

RA Capital Management, L.P. had an annual revenue of $11.9 million in 2025.

The annual revenue of RA Capital Management, L.P. is a significant figure that indicates the company's financial performance.

RA Capital Management, L.P. is a significant player in the industry with 221 people employed.

The number of employees at RA Capital Management, L.P. is substantial, indicating a robust workforce.

Having a large team can be beneficial for a company, allowing for more ideas and perspectives to be shared and considered.

RA Capital Management has a strategic partnership with Xenomorph, a UK-based company, which was announced on July 5, 2022. This partnership was formed after an extensive selection process and proof of concept.

The partnership aims to deliver a comprehensive enterprise data management solution for RA Capital Management's bio-tech and financial data needs. This solution will help RA Capital Management manage its data more efficiently.

RA Capital Management's partnership with Xenomorph was announced in a press release on July 5, 2022, in New York, Boston, and London. The partnership data is sourced from VentureSource.

Explore further: Bank Payment Solutions

SV Health Investors was founded in 1993 and primarily serves sectors such as biotechnology, healthcare technology, and medical devices. It was formerly known as SV Life Sciences and is based in Boston, Massachusetts.

Bedford Bridge focuses on the intersection of technology and biology in healthcare, investing in companies developing solutions in therapeutic development, diagnostics, artificial intelligence, and personalized medicine. It serves the healthcare technology sector.

Catalio Capital Management was founded in 2020 and is based in Baltimore, Maryland. The firm engages in various investment strategies, including private equity investments in biomedical technology companies.

MVM Partners was founded in 1997 and is based in London, United Kingdom. It focuses on high growth healthcare businesses in various sectors including medical technology, pharmaceuticals, and diagnostics.

SV Health Investors and MVM Partners share a focus on high growth healthcare businesses, with SV Health Investors primarily serving sectors such as biotechnology and healthcare technology. MVM Partners provides growth equity to commercial-stage businesses.

Bedford Bridge and Catalio Capital Management were both founded in the 2020s, with Bedford Bridge founded in 2023 and Catalio Capital Management founded in 2020. Both firms focus on innovative healthcare solutions.

SV Health Investors and Catalio Capital Management have been in business for over two decades, with SV Health Investors founded in 1993 and Catalio Capital Management founded in 2020.

See what others are reading: Steward Health Care